Piper Sandler reiterated their overweight rating on shares of Teleflex (NYSE:TFX – Free Report) in a report published on Friday,Benzinga reports. The brokerage currently has a $169.00 price target on the medical technology company’s stock, up from their previous price target of $160.00. Other equities research analysts have also recently issued reports about the company. […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Definium Therapeutics’ (DFTX) “Overweight” Rating Reiterated at Piper Sandler | 0 | 8.75 | 10-08-2026 |
| 2 | STERIS’s (STE) “Overweight” Rating Reiterated at Piper Sandler | 0 | 9.98 | 10-08-2026 |
| 3 | Sotera Health’s (SHC) Overweight Rating Reiterated at Piper Sandler | 0 | 9.05 | 10-08-2026 |
| 4 | Piper Sandler Cuts ResMed (NYSE:RMD) Price Target to $225.00 | 0 | 10.45 | 10-08-2026 |
| 5 | Shoulder Innovations’ (SI) Overweight Rating Reiterated at Piper Sandler | 0 | 8.45 | 10-08-2026 |
| 6 | ICU Medical (NASDAQ:ICUI) Price Target Raised to $195.00 | 0 | 11.84 | 10-08-2026 |
| 7 | Doximity’s (DOCS) “Overweight” Rating Reiterated at Piper Sandler | 0 | 9.98 | 10-08-2026 |
| 8 | Twilio (NYSE:TWLO) Price Target Raised to $247.00 | 0 | 12.6 | 10-08-2026 |
| 9 | Somnigroup International’s (SGI) “Overweight” Rating Reiterated at Piper Sandler | 0 | 9.05 | 10-08-2026 |
| 10 | Becton, Dickinson and Company (NYSE:BDX) Price Target Raised to $175.00 | 0 | 12.26 | 10-08-2026 |